Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/28378
Title: The control of treated generalized and focal epilepsies during pregnancy.
Austin Authors: Vajda, Frank J E;Brien, Terence J O';Graham, Janet E;Hitchcock, Alison A;Perucca, Piero ;Lander, Cecilie M;Eadie, Mervyn J
Affiliation: Comprehensive Epilepsy Program
Medicine (University of Melbourne)
Department of Neuroscience, Monash University, Melbourne, VIC 3004, Australia
Royal Brisbane and Women's Hospital and School of Medicine and Biomedical Science, University of Queensland, Brisbane, QLD 4027, Australia
Departments of Medicine and Neurosciences, The Royal Melbourne Hospital, The University of Melbourne, Parkville, Victoria 3050, Australia
Department of Neurology, Alfred Health, Melbourne, VIC 3004, Australia
Issue Date: Dec-2021
Date: 2021-11-11
Publication information: Epilepsy & Behavior 2021; 125: 108406
Abstract: To examine factors contributing to failure to achieve full seizure control during pregnancy in women with anti-seizure medication (ASM) treated generalized epilepsy compared with focal epilepsy. Full seizure control was not attained in 51.4% of 1223 pregnancies of women with focal epilepsies in the Australian Pregnancy Register, and in 38.7% of 1026 pregnancies in women with generalized epilepsy (P < 0.05). For convulsive seizures only, the corresponding figures of 20.8% and 22.9% were reasonably similar. Where seizures had occurred in the pre-pregnancy year, 82.5% of the focal epilepsy pregnancies were seizure affected, and 70.1% of the generalized epilepsy ones (P < 0.05). Where the pre-pregnancy year was seizure free, the corresponding figures were 22.6% and 16.4% (P < 0.05), a roughly four-fold lower rate. Maternal age, epilepsy onset age, and epilepsy duration also differed between the focal and generalized epilepsy pregnancies. Multivariate regression analysis showed that generalized epilepsy and younger maternal age were associated with statistically significant decreased risks of seizure-affected pregnancy, and having seizure-affected pre-pregnancy years with an increased risk. However, for convulsive seizures only, the risk of seizure-affected pregnancy appeared increased in generalized epilepsy. The risk of seizure-affected pregnancy appears lower in women with generalized epilepsy, independently of pre-pregnancy seizure control, itself a major determinant of the risk. The risk of having only convulsive seizures in pregnancy was not lower in generalized epilepsy than in focal epilepsy. ASM therapy seemed less effective in controlling focal than generalized epileptic seizures during pregnancy.
URI: https://ahro.austin.org.au/austinjspui/handle/1/28378
DOI: 10.1016/j.yebeh.2021.108406
ORCID: 0000-0002-7855-7066
Journal: Epilepsy & Behavior : E&B
PubMed URL: 34775246
PubMed URL: https://pubmed.ncbi.nlm.nih.gov/34775246/
Type: Journal Article
Subjects: Anti-seizure medication
Control
Focal epilepsy
Generalized epilepsy
Pregnancy
Seizure
Appears in Collections:Journal articles

Show full item record

Page view(s)

22
checked on Mar 1, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.